Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$30.90 USD
+0.22 (0.72%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $30.90 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Omega Healthcare Investors, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 950 | 878 | 1,063 | 892 | 929 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 950 | 878 | 1,063 | 892 | 929 |
Selling & Adminstrative & Depr. & Amort Expenses | 558 | 566 | 542 | 512 | 377 |
Income After Depreciation & Amortization | 392 | 312 | 520 | 381 | 552 |
Non-Operating Income | 99 | 358 | 130 | 5 | 1 |
Interest Expense | 236 | 233 | 235 | 223 | 209 |
Pretax Income | 256 | 436 | 416 | 162 | 344 |
Income Taxes | 6 | 5 | 4 | 5 | 3 |
Minority Interest | 7 | 12 | 12 | 4 | 11 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | -1 | 7 | 16 | 6 | 11 |
Income From Cont. Operations | 249 | 439 | 428 | 164 | 352 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 242 | 427 | 417 | 159 | 341 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 716 | 652 | 896 | 708 | 857 |
Depreciation & Amortization (Cash Flow) | 324 | 340 | 376 | 327 | 305 |
Income After Depreciation & Amortization | 392 | 312 | 520 | 381 | 552 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 250.45 | 244.29 | 244.34 | 235.10 | 222.13 |
Diluted EPS Before Non-Recurring Items | 1.00 | 1.80 | 1.75 | 0.70 | 1.58 |
Diluted Net EPS (GAAP) | 1.00 | 1.80 | 1.75 | 0.70 | 1.58 |
Fiscal Year end for Omega Healthcare Investors, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 239.32 | 242.03 | 250.19 | 218.20 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 239.32 | 242.03 | 250.19 | 218.20 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 138.44 | 135.72 | 142.61 | 141.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 100.88 | 106.31 | 107.58 | 76.92 |
Non-Operating Income | NA | 20.37 | 49.48 | 13.27 | 16.35 |
Interest Expense | NA | 59.43 | 58.78 | 58.78 | 58.55 |
Pretax Income | NA | 61.82 | 97.01 | 62.08 | 34.72 |
Income Taxes | NA | 4.16 | 1.76 | 1.63 | -1.29 |
Minority Interest | NA | 1.52 | 2.53 | 1.67 | 0.90 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | -1.14 | -1.35 | 1.07 | 0.83 |
Income From Cont. Operations | NA | 56.52 | 93.91 | 61.52 | 36.85 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 55.00 | 91.38 | 59.86 | 35.94 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 256.56 | 255.96 | 246.10 | 243.19 |
Diluted EPS Before Non-Recurring Items | NA | 0.22 | 0.37 | 0.25 | 0.15 |
Diluted Net EPS (GAAP) | NA | 0.23 | 0.37 | 0.25 | 0.15 |